GlassScriptPhysician profile
Kelli Spivey
NPI 1912415092
$5,191.88
in general payments reported to CMS, 2019-2025
35 companies · $614 in 2025
The $614 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,208 · 2022: $1,145 · 2023: $614 · 2024: $612 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $810.82 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $635.74 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $362.93 | 2021-2025 | |
| Amarin Pharma, INC. | $362.03 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $301.32 | 2021-2023 | |
| Esperion Therapeutics, INC. | $290.82 | 2021-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $260.68 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.85 | 2021-2025 | Lifevest |
| Pfizer INC. | $231.74 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $191.77 | 2021-2023 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $150.45 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Boston Scientific Corporation | $143.44 | 2021-2025 | Watchman Access System, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.26 | 2021-2025 | Jardiance |
| Scpharmaceuticals INC. | $100.22 | 2023-2024 | |
| Abbott Laboratories | $85.01 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $83.88 | 2025 | Attruby |
| Philips North America LLC | $76.64 | 2023-2024 | (5044) Mcot |
| Abiomed | $73.51 | 2024-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $61.24 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $58.87 | 2022-2025 | Amvuttra |
| Edwards Lifesciences Corporation | $57.96 | 2022-2025 | Sapien 3 Ultra Resilia |
| Vital Connect, INC | $55.63 | 2025 | Vitalpatch Rtm |
| E.R. Squibb & Sons, L.L.C. | $55.30 | 2021-2022 | |
| Astellas Pharma US INC | $54.11 | 2021 | |
| Cvrx, INC. | $50.64 | 2024 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $41.67 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $33.83 | 2021 | |
| Glaxosmithkline, LLC. | $29.18 | 2025 | Arexvy, Shingrix |
| Sobi, INC | $25.48 | 2022 | |
| Kestra Medical Technology Services, INC. | $25.25 | 2022 | |
| Atricure, INC. | $24.59 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Irhythm Technologies, INC. | $19.99 | 2023 | Zio Xt Patch |
| Baxter Healthcare | $19.85 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $19.45 | 2024 | Evkeeza |
| Tactile Systems Technology INC | $17.73 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Spivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.